...
首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies.
【24h】

Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies.

机译:κ-阿片受体激动剂布雷马西星对虹膜睫状睫状体肌醇磷酸酯形成的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The goal of the current study was to examine the effect of the kappa-opioid agonist, bremazocine (BRE), on inositol phosphate (IP) formation in the rabbit iris-ciliary body (ICB). Concentrations of BRE (10(-7) to 10(-5) M) augmented levels of IP. Incubation of ICBs with BRE (10(-6) M) produced a time-dependent increase in IP levels that peaked at 60 s and declined to basal levels by 5 min. The increase in IP levels produced by BRE (10(-6) M) was inhibited by the kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI, 10(-7) to 10(-5) M) and by activation of PKC with PDBu (10(-7) M). These results demonstrate that kappa-opioid receptor activation by BRE in the rabbit ICB is linked to IP production. Thus, opioid agonist-induced increases in IP activity could play a role in BRE-induced increases in atrial natriuretic peptide release and alterations in aqueous humor dynamics.
机译:本研究的目的是检查κ阿片类激动剂溴咪唑嗪(BRE)对家兔虹膜睫状体(ICB)中肌醇磷酸酯(IP)形成的影响。 BRE(10(-7)到10(-5)M)的浓度增加了IP的水平。用BRE(10(-6)M)孵育ICB会产生IP随时间的增加,IP浓度在60 s达到峰值,并在5分钟内降至基础水平。由BRE(10(-6)M)产生的IP水平增加受到κ阿片受体拮抗剂nor-binaltorphimine(nor-BNI,10(-7)至10(-5)M)和激活的抑制PDBu(10(-7)M)制备的PKC。这些结果表明,兔ICB中BRE激活的κ阿片受体与IP产生有关。因此,阿片激动剂诱导的IP活性增加可能在BRE诱导的心钠素释放和房水动力学改变中起一定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号